Balance Sheet - Design Therapeutics, Inc. (DSGN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.22 | 0.25 | 0.28 | 0.33 | 0.38 | 0.04 | 0.00 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.00 | 0.00 | 0.00 | ||||
| Other current assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total current assets | 0.22 | 0.25 | 0.28 | 0.34 | 0.39 | 0.04 | 0.00 |
| Total non-current assets | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Total assets | 0.23 | 0.25 | 0.29 | 0.34 | 0.39 | 0.04 | 0.00 |
| Total current liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 |
| Total liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | 0.00 |
| Total stockholders' equity | 0.21 | 0.24 | 0.28 | 0.33 | 0.38 | -0.01 | 0.00 |
| Common shares outstanding | 57 | 57 | 56 | 56 | 46 | 27 | 27 |
Show Quarterly Balance Sheet
Balance Sheet - Design Therapeutics, Inc. (DSGN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.22 | 0.22 | 0.21 | 0.22 | 0.23 | 0.25 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.32 | 0.33 | 0.34 | 0.36 | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.04 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Other current assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total current assets | 0.23 | 0.22 | 0.21 | 0.22 | 0.23 | 0.25 | 0.26 | 0.26 | 0.27 | 0.28 | 0.29 | 0.31 | 0.32 | 0.34 | 0.35 | 0.36 | 0.37 | 0.39 | 0.40 | 0.40 | 0.41 | 0.04 | 0.00 | ||
| Total non-current assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Total assets | 0.23 | 0.23 | 0.21 | 0.22 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.31 | 0.32 | 0.34 | 0.35 | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | 0.41 | 0.04 | |||
| Total current liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |||
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | |||
| Total liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.05 | |||
| Total stockholders' equity | 0.22 | 0.21 | 0.20 | 0.21 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.28 | 0.30 | 0.31 | 0.33 | 0.34 | 0.36 | 0.37 | 0.38 | 0.39 | 0.40 | 0.41 | -0.01 | 0.00 | ||
| Common shares outstanding | 61 | 57 | 57 | 57 | 57 | 57 | 57 | 57 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 56 | 55 | 55 | 55 | 18 | 27 | 27 | 27 | 27 |